C 12 H 12 ClNO 2 S 3 , triclinic, P¯ (no. 2), a = 4.4065(7) Å, b = 12.326(2) Å, c = 13.399(2) Å, β = 96.032(6)°, V = 718.2(2) Å 3 , Z = 2, Rgt(F) = 0.0668, wR(F 2 ) = 0.164, T = 100 K.
The crystal structure is shown in the gure. Tables 1-3 contain details of the measurement method and a list of the atoms including atomic coordinates and displacement parameters.
Source of material
The chemical reagents and solvents used in this study are commercially available. The synthesis of (Z)-5-(4-chlorobenzylidene)-2-thioxothiazolidin-4-one follows a reported synthesis [1] . The product was recrystallized from DMSO. All data are matching with reported procedures [1] . 
Atom Site
x y z U U U U U U Cl( ) i . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) . ( ) S( ) i . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) − . ( ) . ( ) S( ) i . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) − . ( ) . ( ) O( ) i . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) − . ( ) . ( ) N( ) i . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) . ( ) C( ) i .( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) .( ) − . ( ) C( ) i .( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) .( ) C( ) i .( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) .( ) − . ( ) C( ) i .( ) . ( ) . ( ) . ( ) . ( ) .( ) − . ( ) . ( ) − . ( ) C( ) i .( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) .( ) C( ) i .( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) .( ) C( ) i .( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) .( ) C( ) i . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) C( ) i . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) − . ( ) . ( ) C( ) i . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) . ( ) . ( ) S( ) i − . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) O( ) i . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) . ( ) . ( ) C( ) i − . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) C( ) i − . ( ) . ( ) − . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) . ( )
Discussion
The 2-thioxothiazolidin-4-one (Rhodanine) skeleton represents the key pharmacophore of several pharmaceutically agents. Thus, several substituted 2-thioxothiazolidin-4-one for example pioglitazone (hypoglycemic), etozoline (antihypertensive), thiazolidomycin (activity against Streptomyces species), and ralitoline (anticonvulsant), based on this pharmacophore are already in the market. On the other hand, this sca old shows antifungal, antibacterial, antiviral, anti-in ammatory, anticonvulsant, anti-diabetic, anti-proliferative, anti-tubercular, anti-hyperlipidemic, and cardiovascular activities. In continues of our research [2, 3] we report the crystal structure of a new thioxothiazolidin-4-one compound [4] [5] [6] . The title compound, C 12 H 12 ClNO 2 S 3 comprise of a planar thioxothiazolidin-4-one heterocycle (S2-C1/N1/C2/C3). A chlorobenzylidene moiety is connected to C3. The dihedral angle between the two rings is 5.79(2)°. The asymmetric unit involves a dimethylsulfoxide (DMSO) solvate molecules which plays a crucial role in the stabilization of the molecular crystal structure because of its NH· · · O hydrogen bond.
